Is FDMT stock safe? | Glauxie AI

Q: Is FDMT stock safe?

4D Molecular Therapeutics, Inc. (FDMT) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO David H. Kirn. 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product... Employees: 40,000.

Q: What are the risks of investing in FDMT?

Identify key risks of investing in FDMT — debt, competition, volatility, and sector headwinds.

Q: Is FDMT a good long-term investment?

Evaluate FDMT as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does FDMT have?

Review FDMT total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is FDMT stock safe?

🦉

4D Molecular Therapeutics, Inc. (FDMT)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODavid H. Kirn

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has...

Key Executives

Name	Title
An Song	Chief Translational Medicine Advisor
Ashoo Gupta	Principal Accounting Officer & Principal Financial Officer
David H. Kirn	Co-Founder, President, CEO & Director
Fariborz Kamal	Chief Technical Advisor
John F. Milligan	Executive Chairman
Julian Pei	Head of Investor Relations & Corporate Finance

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

FDMT Profile Financials

What are the risks of investing in FDMT? Is FDMT a good long-term investment? How much debt does FDMT have?